Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial
Authors
Keywords
-
Journal
PSYCHOLOGICAL MEDICINE
Volume -, Issue -, Pages 1-9
Publisher
Cambridge University Press (CUP)
Online
2020-11-20
DOI
10.1017/s0033291720004286
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Baseline reward processing and ventrostriatal dopamine function are associated with pramipexole response in depression
- (2020) Alexis E Whitton et al. BRAIN
- Pretreatment reward sensitivity and frontostriatal resting-state functional connectivity are associated with response to bupropion after sertraline non-response
- (2020) Yuen-Siang Ang et al. BIOLOGICAL PSYCHIATRY
- Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression
- (2018) Diego A. Pizzagalli et al. JAMA Psychiatry
- A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial
- (2018) Madhukar H. Trivedi et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- A Systematic Review of Cognitive Predictors of Treatment Outcome in Major Depression
- (2018) Samantha J. Groves et al. Frontiers in Psychiatry
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- A simple attention test in the acute phase of a major depressive episode is predictive of later functional remission
- (2016) Marie-Laure Cléry-Melin et al. DEPRESSION AND ANXIETY
- Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design
- (2016) Madhukar H. Trivedi et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Mechanisms of the placebo effect in pain and psychiatric disorders
- (2016) R D Holmes et al. PHARMACOGENOMICS JOURNAL
- Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression
- (2016) B R Godlewska et al. Translational Psychiatry
- Issues encountered in recent attempts to develop novel antidepressant agents
- (2015) Alan F. Schatzberg Annals of the New York Academy of Sciences
- The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
- (2015) Paul E. Greenberg et al. JOURNAL OF CLINICAL PSYCHIATRY
- Improved Alertness Is Associated with Early Increase in Serum Brain-Derived Neurotrophic Factor and Antidepressant Treatment Outcome in Major Depression
- (2015) Thorsten Mikoteit et al. NEUROPSYCHOBIOLOGY
- Cognitive control, reward-related decision making and outcomes of late-life depression treated with an antidepressant
- (2015) G. S. Alexopoulos et al. PSYCHOLOGICAL MEDICINE
- Emotion recognition processing as early predictor of response to 8-week citalopram treatment in late-life depression
- (2014) Paulo R. Shiroma et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression
- (2014) Paulo R. Shiroma et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Neurocognitive predictors of antidepressant clinical response
- (2014) Gerard E. Bruder et al. JOURNAL OF AFFECTIVE DISORDERS
- A Cognitive–Emotional Biomarker for Predicting Remission with Antidepressant Medications: A Report from the iSPOT-D Trial
- (2014) Amit Etkin et al. NEUROPSYCHOPHARMACOLOGY
- Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial
- (2014) James W Murrough et al. NEUROPSYCHOPHARMACOLOGY
- The placebo response in medicine: minimize, maximize or personalize?
- (2013) Paul Enck et al. NATURE REVIEWS DRUG DISCOVERY
- Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
- (2013) James W. Murrough et al. PSYCHOPHARMACOLOGY
- Reduced Reward Learning Predicts Outcome in Major Depressive Disorder
- (2012) Elske Vrieze et al. BIOLOGICAL PSYCHIATRY
- Prediction of remission of depression with clinical variables, neuropsychological performance, and serotonergic/dopaminergic gene polymorphisms
- (2012) Esteve Gudayol-Ferré et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- A comprehensive assessment of neurocognition in middle-aged chronic cigarette smokers
- (2011) Timothy C. Durazzo et al. DRUG AND ALCOHOL DEPENDENCE
- Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: A longitudinal study
- (2011) Kim Hinkelmann et al. PSYCHONEUROENDOCRINOLOGY
- Antidepressant Drug Effects and Depression Severity
- (2010) Jay C. Fournier et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The role of clinical variables, neuropsychological performance and SLC6A4 and COMT gene polymorphisms on the prediction of early response to fluoxetine in major depressive disorder
- (2010) Esteve Gudayol-Ferré et al. JOURNAL OF AFFECTIVE DISORDERS
- Effects of selective serotonin reuptake and dual serotonergic–noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder
- (2010) Ixchel Herrera-Guzmán et al. PSYCHIATRY RESEARCH
- Dissecting components of reward: ‘liking’, ‘wanting’, and learning
- (2009) Kent C Berridge et al. CURRENT OPINION IN PHARMACOLOGY
- The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients
- (2009) Richard Tranter et al. JOURNAL OF AFFECTIVE DISORDERS
- Smoking and Cognitive Decline Among Middle-Aged Men and Women: The Doetinchem Cohort Study
- (2008) Astrid C. J. Nooyens et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects
- (2008) Marianne Gorlyn et al. JOURNAL OF NEURAL TRANSMISSION
- Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder
- (2008) Ixchel Herrera-Guzmán et al. PSYCHIATRY RESEARCH
- Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis
- (2008) S. Reppermund et al. PSYCHOLOGICAL MEDICINE
- Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration
- (2008) Irving Kirsch et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started